12 studies found for:    Open Studies | "Cholera"
Show Display Options
Rank Status Study
1 Recruiting Introduction of Cholera Vaccine in Bangladesh
Condition: Cholera
Interventions: Biological: ShanChol;   Behavioral: Vaccine and behaviour
2 Recruiting Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh
Condition: Cholera
Interventions: Biological: Shanchol;   Biological: Placebo
3 Unknown  Immunity to Human Cholera in Bangladesh
Condition: Cholera
Intervention:
4 Recruiting A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines
Condition: Cholera
Intervention: Biological: Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
5 Not yet recruiting Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
Conditions: Cholera;   Diarrhea;   Vibrio Infections
Interventions: Biological: Bivalent killed oral cholera vaccine;   Biological: Killed Escherichia coli K12 placebo
6 Recruiting Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine
Condition: Cholera
Intervention:
7 Recruiting Oral Cholera Vaccine Delivery in Rural Bangladesh
Condition: Cholera
Intervention: Biological: Shanchol vaccine
8 Not yet recruiting PXVX0200 (CVD103-HgR) vs Shanchol in Mali
Condition: Cholera
Interventions: Biological: PXVX0200 10E8;   Biological: PXVX0200 10E9;   Biological: Placebo;   Biological: Shanchol
9 Recruiting To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh
Condition: Healthy
Interventions: Biological: ShanChol Cholera Vaccine;   Other: Placebo
10 Unknown  Mucosal Response in Immunocompromised Host
Conditions: Vaccination;   Kidney Transplantation
Intervention: Biological: Dukoral
11 Recruiting Field Application of Shanchol in Adults in Bangladesh
Condition: Other Specified Effects of Reduced Temperature
Intervention: Drug: Shanchol
12 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure)
Intervention: Drug: Ampicillin

Indicates status has not been verified in more than two years